《復牌公告》中信大錳(01091.HK):控股權易手
中信大錳(01091.HK)公布,獲悉中信資源(01205.HK)的間接全資子公司Highkeen簽訂買賣協議,以每股0.92元出售其持有之全數公司股份,即11.79億股或34.39%股權。
出售完成後,中國中信集團將繼續持有公司9.07%股權,不再是公司控股股東,另外,中信資源及Highkeen將不再持有公司股份及不再是公司控股股東。公司今早復牌。
經董事作出一切合理查詢後,就董事所知、所悉及所信,買方及其最終實益擁有人獨立於公司及其關連人士及聯繫人,且與公司及其關連人士及聯繫人無關。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.